Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.

Fujimoto M, Yasuda H, Arai E, Nakajima M, Takata S, Morikawa K, Tanaka H, Itani H, Honda T, Horiuchi K, Watanabe K, Nakagawa H, Nakahara Y, Seki Y, Bessho A, Takahashi N, Hayashi K, Endo T, Takeyama K, Maekura T, Takigawa N, Kawase A, Endoh M, Nemoto K, Kishi K, Soejima K, Okuma Y, Togashi A, Matsutani N, Seki N, Kanai Y

Open source

DOI: 10.1186/s13148-025-01870-8
Published: 2025 Apr 25
Container: Clinical epigenetics
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13148-025-01870-8,
  title = {Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.},
  author = {Fujimoto M and Yasuda H and Arai E and Nakajima M and Takata S and Morikawa K and Tanaka H and Itani H and Honda T and Horiuchi K and Watanabe K and Nakagawa H and Nakahara Y and Seki Y and Bessho A and Takahashi N and Hayashi K and Endo T and Takeyama K and Maekura T and Takigawa N and Kawase A and Endoh M and Nemoto K and Kishi K and Soejima K and Okuma Y and Togashi A and Matsutani N and Seki N and Kanai Y},
  year = {2025},
  journal = {Clinical epigenetics},
  doi = {10.1186/s13148-025-01870-8},
  url = {https://doi.org/10.1186/s13148-025-01870-8}
}

RIS

TY  - JOUR
TI  - Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.
AU  - Fujimoto M
AU  - Yasuda H
AU  - Arai E
AU  - Nakajima M
AU  - Takata S
AU  - Morikawa K
AU  - Tanaka H
AU  - Itani H
AU  - Honda T
AU  - Horiuchi K
AU  - Watanabe K
AU  - Nakagawa H
AU  - Nakahara Y
AU  - Seki Y
AU  - Bessho A
AU  - Takahashi N
AU  - Hayashi K
AU  - Endo T
AU  - Takeyama K
AU  - Maekura T
AU  - Takigawa N
AU  - Kawase A
AU  - Endoh M
AU  - Nemoto K
AU  - Kishi K
AU  - Soejima K
AU  - Okuma Y
AU  - Togashi A
AU  - Matsutani N
AU  - Seki N
AU  - Kanai Y
PY  - 2025
JO  - Clinical epigenetics
DO  - 10.1186/s13148-025-01870-8
UR  - https://doi.org/10.1186/s13148-025-01870-8
ER  -

APA

M, F., H, Y., E, A., M, N., S, T., K, M., H, T., H, I., T, H., K, H., K, W., H, N., Y, N., Y, S., A, B., N, T., K, H., T, E., K, T., T, M., N, T., A, K., M, E., K, N., K, K., K, S., Y, O., A, T., N, M., N, S., & Y, K. (2025). Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.. Clinical epigenetics. https://doi.org/10.1186/s13148-025-01870-8

Source records

pubmed · retrieved 2026-09-26T07:01:11.549Z